Proteasome Inhibition After Burn Injury

about

Effects of a caspase and a calpain inhibitor on resting energy expenditures in normal and hypermetabolic rats: a pilot study Cardiovascular Responsiveness to Vasopressin and α1-Adrenergic Receptor Agonists After Burn Injury.

P2860

Q33864903-3AF595A9-9160-440C-9231-74D966C568DE Q50976101-801DD95E-0BE1-445C-8E40-1862D9D05D2E

P2860

Proteasome Inhibition After Burn Injury

Item

http://www.wikidata.org/entity/Q36487994

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Proteasome Inhibition After Burn Injury

@ast

Proteasome Inhibition After Burn Injury

@en

type

Item

label

Proteasome Inhibition After Burn Injury

@ast

Proteasome Inhibition After Burn Injury

@en

prefLabel

Proteasome Inhibition After Burn Injury

@ast

Proteasome Inhibition After Burn Injury

@en

P1476

Proteasome Inhibition After Burn Injury

@en

P2093

Heather M LaPorte

http://www.w3.org/2001/XMLSchema#string

Matthias Majetschak

http://www.w3.org/2001/XMLSchema#string

P Geoff Vana

http://www.w3.org/2001/XMLSchema#string

Richard H Kennedy

http://www.w3.org/2001/XMLSchema#string

Richard L Gamelli

http://www.w3.org/2001/XMLSchema#string

Yee M Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Anabolic effects of oxandrolone after severe burn

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

The impact of severe burns on skeletal muscle mitochondrial function

The ubiquitin system for protein degradation

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.

U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Cardiotoxicity of the anticancer therapeutic agent bortezomib.

Long-term persistance of the pathophysiologic response to severe burn injury.

P304

207-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/BCR.0000000000000280

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26204383

http://www.w3.org/2001/XMLSchema#string

P932

4721944

http://www.w3.org/2001/XMLSchema#string

Proteasome Inhibition After Burn Injury

about

P2860

P2860

Proteasome Inhibition After Burn Injury

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932